Federal health officials on Wednesday said an outbreak of infant botulism tied to recalled ByHeart baby formula has expanded to include all illnesses reported since the company began production in March 2022.

Investigations by the U.S. Food and Drug Administration and ByHeart are still ongoing to determine what originally caused the outbreak, but health officials warned that all ByHeart formula ever produced could have been contaminated.

In an update shared Wednesday, the FDA said it "cannot rule out the possibility that contamination might have affected all ByHeart formula products." Because of that, the U.S. Centers for Disease Control and Prevention, which is also investigating the outbreak, has expanded the scope of their probe to include any infant infected with botulism

See Full Page